Background: many Juvenile Idiopathic Arthritis (JIA) patients reach inactivity while medicated, but there are no guidelines to determine the moment or method for discontinuing medications. We present the flare rates and remission and possible influencing factors after therapy discontinuation in children with JIA. Methods: data was collected from charts of JIA patients (n=70) in remission on medication, who had their drugs withdrawn. Results: Seventy patients fulfilled inclusion criteria and were included for analysis. The mean time of inactive disease on medication until tapering or withdrawal was 15.6±6.7 months; 45 (64.3%) patients remained in remission and 25 (35.7%) flared. There was no difference between groups regarding sex, age, JIA...
Objective. To determine the elapsed time while receiving aggressive therapy to the first observation...
Objectives: The study aimed to determine the factors that increase the risk of disease flare in pati...
Abstract Background Juvenile idiopathic arthritis (JIA) treatment is aimed at inducing remission to ...
OBJECTIVE: To assess the time in remission after discontinuing biologic therapy in patients with ju...
BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) have changed the treatment of j...
Objectives To determine the reasons of methotrexate (MTX) discontinuation, frequency of adverse even...
OBJECTIVE: to assess the time in remission after discontinuing biologic therapy in JIA patients. MET...
Objective: To characterize articular and systemic inflammatory activity in juvenile idiopathic arthr...
Context Novel therapies have improved the remission rate in chronic inflammatory disorders including...
BACKGROUND: Children with juvenile idiopathic arthritis (JIA) who achieve a drug free remission ofte...
This article is protected by copyright. All rights reserved.Peer reviewedPostprin
Context Novel therapies have improved the remission rate in chronic inflammatory disorders including...
Juvenile idiopathic arthritis constitutes a significant cause of disability and quality of life impa...
ObjectivesTo determine (i) correlates for etanercept (ETA) discontinuation after achieving an inacti...
Objective To study juvenile idiopathic arthritis (JIA) long-term outcomes in relation to the time of...
Objective. To determine the elapsed time while receiving aggressive therapy to the first observation...
Objectives: The study aimed to determine the factors that increase the risk of disease flare in pati...
Abstract Background Juvenile idiopathic arthritis (JIA) treatment is aimed at inducing remission to ...
OBJECTIVE: To assess the time in remission after discontinuing biologic therapy in patients with ju...
BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) have changed the treatment of j...
Objectives To determine the reasons of methotrexate (MTX) discontinuation, frequency of adverse even...
OBJECTIVE: to assess the time in remission after discontinuing biologic therapy in JIA patients. MET...
Objective: To characterize articular and systemic inflammatory activity in juvenile idiopathic arthr...
Context Novel therapies have improved the remission rate in chronic inflammatory disorders including...
BACKGROUND: Children with juvenile idiopathic arthritis (JIA) who achieve a drug free remission ofte...
This article is protected by copyright. All rights reserved.Peer reviewedPostprin
Context Novel therapies have improved the remission rate in chronic inflammatory disorders including...
Juvenile idiopathic arthritis constitutes a significant cause of disability and quality of life impa...
ObjectivesTo determine (i) correlates for etanercept (ETA) discontinuation after achieving an inacti...
Objective To study juvenile idiopathic arthritis (JIA) long-term outcomes in relation to the time of...
Objective. To determine the elapsed time while receiving aggressive therapy to the first observation...
Objectives: The study aimed to determine the factors that increase the risk of disease flare in pati...
Abstract Background Juvenile idiopathic arthritis (JIA) treatment is aimed at inducing remission to ...